Sun Pharmaceutical Industries Ltd, the sixth-largest generic pharmaceutical manufacturer in the world, had questioned NPPA's demand notice of 2005 for payment of Rs 4.6 crore "to recover the higher price charged in relation to Roscilox, a brand of a Cloxacillin-based drug formulation, than that fixed by the govt under Drugs (Price Control) Order (DPCO)".
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/Rs7tx82
Subscribe to:
Post Comments (Atom)
Sri Lanka central bank fines Indian Bank
from Business News: Business News, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Bu...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2VEK8DU...
No comments:
Post a Comment